Shizuoka, Japan

Kyoko Takami



 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kyoko Takami: Innovator in Cancer Treatment

Introduction

Kyoko Takami is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of cancer treatment through her innovative research and development of new compounds. With a total of 2 patents, her work focuses on aminopyrazole derivatives that have the potential to revolutionize cancer therapies.

Latest Patents

Kyoko Takami's latest patents include a method for treating cancer that involves administering a pharmaceutically effective amount of a composition containing a compound represented by a specific formula. This compound is designed to target and inhibit fibroblast growth factor receptor (FGFR) family kinases in cancer tissues. The detailed chemical structure of these compounds showcases her expertise in medicinal chemistry and her commitment to advancing cancer treatment options.

Career Highlights

Throughout her career, Kyoko has worked with notable companies such as Chugai Seiyaku Kabushiki Kaisha and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to collaborate with leading experts in the pharmaceutical industry, further enhancing her research capabilities and impact on cancer treatment.

Collaborations

Kyoko has collaborated with esteemed colleagues, including Naoki Taka and Masayuki Ohmori. These partnerships have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Kyoko Takami's contributions to cancer treatment through her innovative patents and collaborations highlight her as a leading figure in the field. Her work continues to inspire advancements in medical research and offers hope for improved cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…